Samsung Snags Second Soliris Biosimilar In US

Following Amgen’s Earlier Nod, Samsung Bioepis Gets FDA Approval For Eculizumab

 
• By Dave Wallace
  
Thumbs up with USA flag
The US FDA has approved Samsung Bioepis’ Epysqli • Source: Shutterstock

More from Biosimilars

More from Products